9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion

Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion

Estimated reading time: < 1 min

Condition: Malignant Pleural Effusion

Estimated Enrollment: 19

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Active, not recruiting

Study Results: No Results Available

Outcome Measures: Safety,  Progression-free survival,  Overall survival,

Interventions: AdV-tk + valacyclovir,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: December 2015

Completion Date: October 2020

Last  Posted Date: February 4, 2019

Location: University of Pennsylvania, Philadelphia, Pennsylvania, United States

Website Link: https://ClinicalTrials.gov/show/NCT01997190

Was this article helpful?
Dislike 0